an2728 and Scleroderma--Localized

an2728 has been researched along with Scleroderma--Localized* in 1 studies

1 trial(s) available for an2728 and Scleroderma--Localized

Article	Year
Pilot, open-label, single-arm clinical trial evaluating the efficacy of topical crisaborole for steroid refractory morphea. Journal of the American Academy of Dermatology, 2023, Volume: 89, Issue:2 Topics: Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Dermatitis, Atopic; Humans; Ointments; Scleroderma, Localized; Treatment Outcome	2023